Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis-Reference-Cited by-同舟云学术

Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis

Published:2022-07-28 Issue:11 Volume:107 Page:2748-2751
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Ardizzoia Federica,Lorentino Francesca,Bruno Alessandro,Marktel Sarah,Giglio Fabio,Clerici Daniela,Farina Francesca,Mastaglio Sara,Piemontese Simona,Assanelli Andrea A.,Carrabba Matteo G.,Bernardi Massimo,Corti Consuelo,Peccatori Jacopo,Ciceri Fabio,Greco Raffaella,Lupo-Stanghellini Maria Teresa

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Reference16 articles.

1. Holtan SG, MacMillan ML. A risk-adapted approach to acute GVHD treatment: are we there yet?. Bone Marrow Transplant. 2016; 51(2):172-175.

2. Ferrara JLM, Chaudhry MS. GVHD: biology matters. Blood Adv. 2018; 2(22):3411-3417.

3. McCurdy SR, Radojcic V, Tsai HL. Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning. Blood. 2022; 139(4):608-623.

4. MacMillan ML, Robin M, Harris AC. A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. Biol Blood Marrow Transplant. 2015; 21(4):761-767.

5. MacMillan ML, DeFor TE, Holtan SG, Rashidi A, Blazar BR, Weisdorf DJ. Validation of Minnesota acute graft-versus-host disease Risk Score. Haematologica. 2020; 105(2):519-524.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease;Bone Marrow Transplantation;2024-08-26

2. Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide;Bone Marrow Transplantation;2024-08-24

3. Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA- matched stem-cell transplantation for AML;2024-03-04

4. Gastrointestinal Involvement Refines Prognosis in Minnesota Standard Risk Acute Graft-vs-Host Disease;2024-02-05